Treatment outcome where there is a greater than 50% decrease in M protein; also referred to as partial remission.
A decrease in the size of a tumor, or the regression by more than 50 percent but less than 100 percent of the extent of cancer in the body.
One of the parameters that is used to assess the activity of potential anti-cancer drugs. In solid tumors, according to the RECIST criteria, a partial response is a 30% or more decrease in the diameter of the tumor at its longest point.
A decrease in the size of a tumor, or in the extent of cancer in the body has regressed by more than 50 percent in response to anticancer treatment.
Usually described as a 50% reduction in the size of a tumor after treatment.
To a researcher, this means the cancer shrinking to at least half the original size for at least four weeks. There must not be any sign of growth of the cancer anywhere else in the body.
A decrease in the total cross sectional area of all measurable tumors of at least 50% but less that 100
A result of cancer treatment that was not able to completely rid the body of the cancer, but did result in either stopping the growth of tumor(s) or caused shrinkage in the tumor(s).
A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment. Also called partial remission.
A post treatment decrsease in the size of a measurable tumor of at least 50%, but less than 100% of the total cros section.
The shrinking, but not complete disappearance, of a tumor in response to therapy. also called partial remission.
